OpenAI has approached Congress for guidance on whether a coordinated slowdown in AI development would violate antitrust laws. Concerns have been raised that such collaboration among AI labs could be seen as restricting output, potentially breaching the Sherman Antitrust Act. Meanwhile, a bipartisan bill has been introduced to allow AI labs to work together on safety without antitrust repercussions.
The debate reflects broader tensions in the AI industry, where competition for market dominance complicates efforts to prioritize safety. Some industry leaders argue that fears of antitrust are masking deeper issues related to differing safety philosophies and competitive pressures.
Watch for developments on the bipartisan bill allowing AI labs to collaborate on safety without antitrust concerns. As tensions rise over differing safety philosophies, industry leaders must find common ground to address risks while navigating competitive pressures.